Impairment occurs when an asset's carrying amount exceeds the amount expected to be recovered through use or sale.
Impairment is the accounting condition that exists when an asset’s carrying amount is greater than the amount expected to be recovered from using or selling it.
When impairment exists, the asset is overstated on the books and must usually be reduced through an Impairment Loss or related Write-Down.
The central comparison is:
If that condition holds, the asset is impaired.
Common indicators include:
Goodwill and other long-lived assets are common impairment subjects.
Impairment protects financial reporting from overstating asset values. It forces management to recognize that the recorded balance can no longer be justified by expected economic benefit.
That is why impairment sits at the intersection of valuation, prudence, and earnings quality.
Depreciation is systematic and expected. Impairment is a separate downward reassessment when value falls faster or farther than the normal allocation schedule would capture.
Analysts use impairment to connect accounting presentation with profitability, asset quality, leverage, liquidity, and reporting quality. The practical analysis asks how the item is recognized, measured, classified, disclosed, and whether it reflects recurring economics or a one-time accounting effect.
A financial-statement review would compare impairment with company policy, prior-period trends, peer treatment, footnotes, and cash-flow evidence. Classification or timing can materially change ratios even when the underlying economics are similar.
Ask whether impairment affects earnings quality, working capital, leverage, cash conversion, asset values, or trend comparability.
Do not treat the accounting label as the economic conclusion. Estimates, policy elections, noncash timing, and one-off adjustments often need separate analysis.
Interpret Impairment as decision evidence, not just a definition. Its weight depends on the transaction, measurement date, jurisdiction, market conditions, and whether Impairment changes cash flow, risk allocation, reported performance, controls, or investor behavior.
The finance relevance comes from how the accounting treatment changes reported performance, cash conversion, valuation inputs, taxes, debt-covenant math, earnings quality, capital allocation, and comparability across companies.
Do not confuse Impairment with the underlying economic event. The accounting treatment explains recognition or measurement; analysis still asks whether cash flow, risk, leverage, and comparability changed.
Treat Impairment as decision-useful only when it changes a forecast, contractual right, accounting result, tax outcome, market price, liquidity need, or risk-control action. If those items do not change, Impairment is descriptive rather than analytical evidence.
Keep Impairment tied to measurement, recognition, presentation, controls, or reconciliation. It should not be used as a broad business-performance claim unless the accounting treatment changes reported income, asset values, liabilities, equity, tax timing, or a financial statement ratio that someone actually relies on.
Use Impairment when a finance review needs to connect accounting language to a decision: closing entries, revenue recognition, asset measurement, covenant compliance, tax planning, or earnings-quality analysis. The useful question for Impairment is not only what the label means, but whether it changes a number someone will rely on.
In practice, check Impairment against the accounting policy or source record, the affected line item or ratio, and the cash-flow or disclosure consequence. If Impairment changes classification without changing economics, note the presentation effect. If it changes timing, measurement, reserves, or comparability, treat it as an analysis item rather than a vocabulary item.
Pull the source journal entry, policy memo, account reconciliation, footnote, and prior-period treatment. For Impairment, the useful evidence is the item that proves recognition, measurement, classification, cutoff, and comparability rather than a generic accounting label.
The practical test for Impairment is whether the accounting treatment changes recognition, measurement, cutoff, classification, disclosure, tax timing, covenant ratios, or comparability. If the answer is yes, confirm the source record and explain the financial statement effect before relying on Impairment.
Verify Impairment against the source entry, accounting policy, period cutoff, supporting schedule, and financial statement line. The key is whether the term changes measurement, classification, disclosure, tax timing, or comparability enough to affect a finance conclusion.
The analysis boundary for Impairment is crossed when the accounting label stops changing measurement, classification, timing, or disclosure. At that point, focus on the underlying cash flow, estimate quality, covenant effect, and comparability rather than repeating the label.
Trace Impairment from source record to journal entry, statement line, footnote, and ratio effect. The finance conclusion is stronger when the path shows who recorded the item, which estimate or policy was applied, and whether the result changes liquidity, leverage, earnings quality, tax timing, or covenant headroom.
The use boundary for Impairment is reached when the accounting label does not change recognition, measurement, cutoff, presentation, disclosure, tax timing, or covenant math. In that case, explain the label but keep the finance conclusion tied to cash flow, controls, and statement effects.
The decision marker for Impairment is the moment the accounting treatment changes a number that someone uses: reported profit, asset value, liability amount, tax timing, covenant headroom, or period comparability. If the number does not change, keep the term in the explanatory layer.
The source check for Impairment is the accounting record that would survive review: journal entry, contract, invoice, valuation support, reconciliation, policy memo, or audited disclosure. Prefer that source over summary labels when Impairment affects reported performance or covenant analysis.
Decision evidence for Impairment should show the affected account, amount, period, policy basis, and reviewer sign-off. Impairment can change analysis only when those items connect cleanly to financial statements, tax treatment, covenant math, or valuation inputs.
Review evidence for Impairment should make the accounting evidence traceable, not just definitional. For Impairment, tie the evidence to the journal entry, account mapping, reconciliation, and supporting schedule and explain why that evidence is reliable enough for the finance decision.
Before relying on Impairment, document the decision context: the reporting period, cutoff convention, and accounting policy in force. Keep the Impairment evidence trail visible: reviewer approval, variance explanation, and any audit trail that ties the term to the financial statements. In Accounting work, Impairment matters when it changes recognition, measurement, classification, disclosure, covenant math, or tax treatment.
The practical risk for Impairment is that weak documentation can turn a clean accounting label into an unsupported adjustment or disclosure gap. If those facts are unavailable, keep Impairment in the explanatory layer instead of treating it as decision-grade evidence.
Impairment is material when it can change a finance conclusion, not just when Impairment appears in a document. For Impairment, test whether the evidence affects recognition, measurement, classification, disclosure, audit evidence, covenant treatment, or tax timing. If those decision points are unchanged, keep Impairment explanatory and avoid overweighting it in the final decision.
A practical materiality check is to name the decision that would change if Impairment is wrong, stale, missing, or tied to the wrong period. Impairment warrants deeper review only when statement users would draw a different conclusion about earnings quality, asset value, liabilities, or control strength.